Atlas Trials

Efficacy and Safety of SP2086 as Monotherapy in Patients With Type 2 Diabetes

Clinical trial NCT01970033 · UNKNOWN

Trial details

NCT number
NCT01970033
Sponsor
Jiangsu HengRui Medicine Co., Ltd.
Status
UNKNOWN
Phase
Phase 3
Study type
INTERVENTIONAL
Type 2 Diabetes
Start date
2012-12-01
Primary completion
2014-01-01
Enrollment
450

View on ClinicalTrials.gov

Track trials programmatically

Sponsors, conditions and status changes through the Atlas API.